Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial.
Maggio A, Kattamis A, Felisi M, Reggiardo G, El-Beshlawy A, Bejaoui M, Sherief L, Christou S, Cosmi C, Della Pasqua O, Del Vecchio GC, Filosa A, Cuccia L, Hassab H, Kreka M, Origa R, Putti MC, Spino M, Telfer P, Tempesta B, Vitrano A, Tsang YC, Zaka A, Tricta F, Bonifazi D, Ceci A. Maggio A, et al. Among authors: ceci a. Lancet Haematol. 2020 Jun;7(6):e469-e478. doi: 10.1016/S2352-3026(20)30100-9. Lancet Haematol. 2020. PMID: 32470438 Clinical Trial.
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years.
Bellanti F, Del Vecchio GC, Putti MC, Maggio A, Filosa A, Cosmi C, Mangiarini L, Spino M, Connelly J, Ceci A, Della Pasqua O; Consortium DEferiprone Evaluation in Paediatrics (DEEP). Bellanti F, et al. Among authors: ceci a. Br J Clin Pharmacol. 2017 Mar;83(3):593-602. doi: 10.1111/bcp.13134. Epub 2016 Nov 6. Br J Clin Pharmacol. 2017. PMID: 27641003 Free PMC article. Clinical Trial.
Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials.
Maggio A, Filosa A, Vitrano A, Aloj G, Kattamis A, Ceci A, Fucharoen S, Cianciulli P, Grady RW, Prossomariti L, Porter JB, Iacono A, Cappellini MD, Bonifazi F, Cassarà F, Harmatz P, Wood J, Gluud C. Maggio A, et al. Among authors: ceci a. Blood Cells Mol Dis. 2011 Oct 15;47(3):166-75. doi: 10.1016/j.bcmd.2011.07.002. Epub 2011 Aug 16. Blood Cells Mol Dis. 2011. PMID: 21843958 Review.
The Italian multiregional thalassemia registry: Centers characteristics, services, and patients' population.
Conte R, Ruggieri L, Gambino A, Bartoloni F, Baiardi P, Bonifazi D, Bonifazi F, Felisi M, Giannuzzi V, Padula R, Pepe A, Putti MC, Del Vecchio GC, Maggio A, Filosa A, Iacono A, Mangiarini L, Ceci A. Conte R, et al. Among authors: ceci a. Hematology. 2016 Aug;21(7):415-24. doi: 10.1080/10245332.2015.1101971. Epub 2016 Feb 22. Hematology. 2016. PMID: 26863102
Pattern of complications and burden of disease in patients affected by beta thalassemia major.
Bonifazi F, Conte R, Baiardi P, Bonifazi D, Felisi M, Giordano P, Giannuzzi V, Iacono A, Padula R, Pepe A, Caterina Putti M, Ruggieri L, Carlo Del Vecchio G, Filosa A, Maggio A, Ceci A; HTA-THAL Multiregional Registry. Bonifazi F, et al. Among authors: ceci a. Curr Med Res Opin. 2017 Aug;33(8):1525-1533. doi: 10.1080/03007995.2017.1326890. Epub 2017 Jun 7. Curr Med Res Opin. 2017. PMID: 28471307
Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study.
Botzenhardt S, Felisi M, Bonifazi D, Del Vecchio GC, Putti MC, Kattamis A, Ceci A, Wong ICK, Neubert A; DEEP consortium (collaborative group). Botzenhardt S, et al. Among authors: ceci a. Haematologica. 2018 Jan;103(1):e1-e4. doi: 10.3324/haematol.2017.176065. Epub 2017 Oct 27. Haematologica. 2018. PMID: 29079595 Free PMC article. No abstract available.
A complication risk score to evaluate clinical severity of thalassaemia syndromes.
Vitrano A, Meloni A, Addario Pollina W, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Hussain Ansari S, Filosa A, Ricchi P, Ceci A, Daar S, Titi Singer S, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Vichinsky E, Maggio A. Vitrano A, et al. Among authors: ceci a. Br J Haematol. 2021 Feb;192(3):626-633. doi: 10.1111/bjh.17203. Epub 2020 Nov 20. Br J Haematol. 2021. PMID: 33216983 Free article.
Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia.
Musallam KM, Vitrano A, Meloni A, Pollina SA, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Ansari SH, Filosa A, Ricchi P, Ceci A, Daar S, Vlachaki E, Singer ST, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Sankaran VG, Vichinsky E, Taher AT, Maggio A. Musallam KM, et al. Among authors: ceci a. Haematologica. 2021 Sep 1;106(9):2489-2492. doi: 10.3324/haematol.2021.278684. Haematologica. 2021. PMID: 33882642 Free PMC article. No abstract available.
Pharmacotherapy of iron overload in thalassaemic patients.
Ceci A, Felisi M, De Sanctis V, De Mattia D. Ceci A, et al. Expert Opin Pharmacother. 2003 Oct;4(10):1763-74. doi: 10.1517/14656566.4.10.1763. Expert Opin Pharmacother. 2003. PMID: 14521486 Review.
188 results